Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.
A surprise finding by two independent research teams and a venture capital mega-round have birthed a biotech looking to treat ...
In a landmark continuing collaboration, Answer ALS and Cedars-Sinai have announced the completed availability of the largest ...
Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for ...
Researchers have uncovered a mechanism that may trigger ALS’s earliest stages, identifying proteins that mislocalize, causing ...
Mitochondrial genome mutations may be linked to ALS, per a study, opening the door for new ways to diagnosing and treating ...
Kadimastem, the developer of the experimental amyotrophic lateral sclerosis (ALS) therapy AstroRx, is merging with NLS ...
Though there is no cure for multiple sclerosis (MS), current treatments often involve disease-modifying therapies (DMTs) that can reduce the frequency of symptom relapses and slow the progression of ...
Oxidative Stress: Neuropathy, Excitability, and Neurodegeneration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback